Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle

Neuropsychopharmacology

Volumn 33, Issue 9, 2008, Pages 2283-2290

  Kask, Kristiina ^a,e   Gulinello, Maria ^b   Bäckström, Torbjörn ^c   Geyer, Mark A ^d   Sundström Poromaa, Inger ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UMEÅ UNIVERSITY   (Sweden)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Estradiol; Menstrual cycle; Premenstrual dysphoric disorder; Prepulse inhibition; Progesterone; Startle response

Indexed keywords

ESTRADIOL; PROGESTERONE; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EYELID REFLEX; FEMALE; FOLLICULAR PHASE; HUMAN; LUTEAL PHASE; MENSTRUAL CYCLE; PREMENSTRUAL DYSPHORIC DISORDER; PREPULSE INHIBITION; PRIORITY JOURNAL; STARTLE REFLEX;

ACOUSTIC STIMULATION; ADULT; BLINKING; FEMALE; HORMONES; HUMANS; INHIBITION (PSYCHOLOGY); LUTEAL PHASE; MIDDLE AGED; PREMENSTRUAL SYNDROME; PROSPECTIVE STUDIES; PSYCHOPHYSICS; STARTLE REACTION; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 47249137366     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301599     Document Type: Article

References (63)

1. Akwa Y, Purdy RH, Koob GF, Britton KT (1999). The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat. Behav Brain Res 106: 119-125.
2. Allen NB, Trinder J, Brennan C (1999). Affective startle modulation in clinical depression: preliminary findings. Biol Psychiatry 46: 542-550.
3. Backstrom T, Andreen L, Birzniece V, Bjorn I, Andersson I-M, Nordenstam-Haghjo M et al (2003). The role of hormones and hormonal treatments in premenstrual syndrome. CNS Drugs 17: 325-342.
4. Bitran D, Hilvers RJ, Kellogg CK (1991). Anxiolytic effects of 3 alpha-hydroxy-5 alpha[beta]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor. Brain Res 561: 157-161.
5. Bitran D, Purdy RH, Kellogg CK (1993). Anxiolytic effect of progesterone is associated with increases in cortical allopregnanolone and GABAA receptor function. Pharmacol Biochem Behav 45: 423-428.
6. Bjorn I, Bixo M, Nojd KS, Collberg P, Nyberg S, Sundstrom-Poromaa I et al (2002). The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy. Gynecol Endocrinol 16: 1-8.
7. Bjorn I, Sundstrom-Poromaa I, Bixo M, Nyberg S, Backstrom G, Backstrom T (2003). Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy. J Clin Endocrinol Metab 88: 2026-2030.
8. Braff DL, Geyer MA, Swerdlow NR (2001). Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156: 234-258.
9. Byrnes EM, Bridges RS, Scanlan VF, Babb JA, Byrnes JJ (2007). Sensorimotor gating and dopamine function in postpartum rats. Neuropsychopharmacology 32: 1021-1031.
10. Davis M (1980). Neurochemical modulation of sensory-motor reactivity: acoustic and tactile startle reflexes. Neurosci Biobehav Rev 4: 241-263.
11. Davis M, Rainnie D, Cassell M (1994). Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci 17: 208-214.
12. Davis M, Walker DL, Lee Y (1997). Roles of the amygdala and bed nucleus of the stria terminalis in fear and anxiety measured with the acoustic startle reflex. Possible relevance to PTSD. Ann NY Acad Sci 821: 305-331.
13. Epperson CN, Haga K, Mason GF, Sellers E, Gueorguieva R, Zhang W et al (2002). Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 59: 851-858.
14. Epperson CN, Pittman B, Czarkowski KA, Stiklus S, Krystal JH, Grillon C (2007). Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder. Neuropsychopharmacology 32: 2190-2198.
15. Eriksson E, Alling C, Andersch B, Andersson K, Berggren U (1994). Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome. Neuropsychopharmacology 11: 201-213.
16. Gallo MA, Smith SS (1993). Progesterone withdrawal decreases latency to and increases duration of electrified prod burial: a possible rat model of PMS anxiety. Pharmacol Biochem Behav 46: 897-904.
17. Gogos A, Nathan PJ, Guille V, Croft RJ, Buuse MV (2006). Estrogen prevents 5-HT(1A) receptor-induced disruptions of prepulse inhibition in healthy women. Neuropsychopharmacology 31: 885-889.
18. Gogos A, Van den Buuse M (2004). Estrogen and progesterone prevent disruption of prepulse inhibition by the serotonin-1A receptor agonist 8-hydroxy-2-dipropylaminotetralin. J Pharmacol Exp Ther 309: 267-274.
19. Grillon C, Morgan III CA, Davis M, Southwick SM (1998). Effects of experimental context and explicit threat cues on acoustic startle in Vietnam veterans with posttraumatic stress disorder. Biol Psychiatry 44: 1027-1036.
20. Gulinello M, Orman R, Smith SS (2003). Sex differences in anxiety, sensorimotor gating and expression of the alpha4 subunit of the GABAA receptor in the amygdala after progesterone withdrawal. Eur J Neurosci 17: 641-648.
21. Gulinello M, Smith SS (2003). Anxiogenic effects of neurosteroid exposure: sex differences and altered GABAA receptor pharmacology in adult rats. J Pharmacol Exp Ther 305: 541-548.
22. Hammarback S, Backstrom T (1988). Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo. Acta Obstet Gynecol Scand 67: 159-166.
23. Hammarback S, Backstrom T, Holst J, von Schoultz B, Lyrenas S (1985). Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestagen postmenopausal replacement therapy. Acta Obstet Gynecol Scand 64: 393-397.
24. Hammarback S, Damber JE, Backstrom T (1989). Relationship between symptom severity and hormone changes in women with premenstrual syndrome. J Clin Endocrinol Metab 68: 125-130.
25. Hammarback S, Ekholm UB, Backstrom T (1991). Spontaneous anovulation causing disappearance of cyclical symptoms in women with the premenstrual syndrome. Acta Endocrinol (Copenh) 125: 132-137.
26. Hauser J, Rudolph U, Keist R, Mohler H, Feldon J, Yee BK (2005). Hippocampal alpha5 subunit-containing GABAA receptors modulate the expression of prepulse inhibition. Mol Psychiatry 10: 201-207.
27. Hoenig K, Hochrein A, Quednow BB, Maier W, Wagner M (2005). Impaired prepulse inhibition of acoustic startle in obsessive-compulsive disorder. Biol Psychiatry 57: 1153-1158.
28. Jovanovic T, Szilagyi S, Chakravorty S, Fiallos AM, Lewison BJ, Parwani A et al (2004). Menstrual cycle phase effects on prepulse inhibition of acoustic startle. Psychophysiology 41: 401-406.
29. Koch M (1999). The neurobiology of startle. Prog Neurobiol 59: 107-128.
30. Lancel M, Faulhaber J, Schiffelholz T, Romeo E, Di Michele F, Holsboer F et al (1997). Allopregnanolone affects sleep in a benzodiazepine-like fashion. J Pharmacol Exp Ther 282: 1213-1218.
31. Landgren S, Wang MD, Backstrom T, Johansson S (1998). Interaction between 3 alpha-hydroxy-5 alpha-pregnan-20-one and carbachol in the control of neuronal excitability in hippocampal slices of female rats in defined phases of the oestrus. Acta Physiol Scand 162: 77-88.
32. Lee Y, Davis M (1997). Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J Neurosci 17: 6434-6446.
33. Ludewig K, Geyer MA, Vollenweider FX (2003). Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia. Biol Psychiatry 54: 121-128.
34. Ludewig S, Ludewig K, Geyer MA, Hell D, Vollenweider FX (2002). Prepulse inhibition deficits in patients with panic disorder. Depress Anxiety 15: 55-60.
35. Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM (1986). Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232: 1004-1007.
36. Moran MH, Smith SS (1998). Progesterone withdrawal I: pro-convulsant effects. Brain Res 807: 84-90.
37. Morgan III CA, Grillon C, Southwick SM, Davis M, Charney DS (1996). Exaggerated acoustic startle reflex in Gulf War veterans with posttraumatic stress disorder. Am J Psychiatry 153: 64-68.
38. Parry BL (2001). The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications. CNS Drugs 15: 277-285.
39. Pissiota A, Frans O, Michelgard A, Appel L, Langstrom B, Flaten MA et al (2003). Amygdala and anterior cingulate cortex activation during affective startle modulation: a PET study of fear. Eur J Neurosci 18: 1325-1331.
40. Plappert CF, Pilz PK (2002). Difference in anxiety and sensitization of the acoustic startle response between the two inbred mouse strains BALB/cAN and dBA/2N. Genes Brain Behav 1: 178-186.
41. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR (1998). Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 338: 209-216.
42. Schmidt PJ, Nieman LK, Grover GN, Muller KL, Merriam GR, Rubinow DR (1991). Lack of effect of induced menses on symptoms in women with premenstrual syndrome. N Engl J Med 324: 1174-1179.
43. Schwegler H, Pilz PK, Koch M, Fendt M, Linke R, Driscoll P (1997). The acoustic startle response in inbred Roman high- and low-avoidance rats. Behav Genet 27: 579-582.
44. Seippel L, Backstrom T (1998). Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome. J Clin Endocrinol Metab 83: 1988-1992.
45. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20): 22-33; quiz 34-57.
46. Shughrue PJ, Lane MV, Merchenthaler I (1997). Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Comp Neurol 388: 507-525.
47. Smith SS, Gong QH, Hsu FC, Markowitz RS, ffrench-Mullen JM, Li X (1998a). GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 392: 926-930.
48. Smith SS, Gong QH, Li X, Moran MH, Bitran D, Frye CA et al (1998b). Withdrawal from 3alpha-OH-5alpha-pregnan-20-One using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor alpha4 subunit in association with increased anxiety. J Neurosci 18: 5275-5284.
49. Stohr T, Szuran T, Pliska V, Feldon J (1999). Behavioural and hormonal differences between two Lewis rat lines. Behav Brain Res 101: 163-172.
50. Sundstrom I, Andersson A, Nyberg S, Ashbrook D, Purdy RH, Backstrom T (1998). Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 67: 126-138.
51. Sundstrom I, Ashbrook D, Backstrom T (1997a). Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study. Psychoneuroendocrinology 22: 25-38.
52. Sundstrom I, Nyberg S, Backstrom T (1997b). Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects. Neuropsychopharmacology 17: 370-381.
53. Sundstrom I, Nyberg S, Bixo M, Hammarback S, Backstrom T (1999). Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen. Acta Obstet Gynecol Scand 78: 891-899.
54. Swerdlow NR, Auerbach P, Monroe SM, Hartston H, Geyer MA, Braff DL (1993). Men are more inhibited than women by weak prepulses. Biol Psychiatry 34: 253-260.
55. Swerdlow NR, Hartman PL, Auerbach PP (1997). Changes in sensorimotor inhibition across the menstrual cycle: implications for neuropsychiatric disorders. Biol Psychiatry 41: 452-460.
56. Swerdlow NR, Light GA, Cadenhead KS, Sprock J, Hsieh MH, Braff DL (2006). Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Arch Gen Psychiatry 63: 1325-1335.
57. Timby E, Balgard M, Nyberg S et al (2006). Pharmacokinetic and behavioral effects of allopregnanolone in healthy women. Psychopharmacology (Berl) 186: 414-424.
58. Toufexis DJ, Davis C, Hammond A, Davis M (2004). Progesterone attenuates corticotropin-releasing factor-enhanced but not fear-potentiated startle via the activity of its neuroactive metabolite, allopregnanolone. J Neurosci 24: 10280-10287.
59. Toufexis DJ, Rochford J, Walker CD (1999). Lactation-induced reduction in rats' acoustic startle is associated with changes in noradrenergic neurotransmission. Behav Neurosci 113: 176-184.
60. Vaillancourt C, Cyr M, Rochford J, Boksa P, Di Paolo T (2002). Effects of ovariectomy and estradiol on acoustic startle responses in rats. Pharmacol Biochem Behav 74: 103-109.
61. Van den Buuse M, Eikelis N (2001). Estrogen increases prepulse inhibition of acoustic startle in rats. Eur J Pharmacol 425: 33-41.
62. Wang MD, Landgren S, Backstrom T (1997). The effects of allopregnanolone, pregnenolone sulphate and pregnenolone on the CA1 population spike of the rat hippocampus after 17 beta-oestradiol priming. Acta Physiol Scand 159: 343-344.
63. Yee BK, Keist R, von Boehmer L et al (2005). A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction. Proc Natl Acad Sci 102: 17154-17159.